Radar mondial UDTR

UDTR — Radar mondial des droits de la Nature

Registre documentaire des références détectées à travers les infrastructures académiques, juridiques et institutionnelles surveillées par UDTR.

Une infrastructure documentaire mondiale conçue pour atteindre la couverture la plus large, vérifiable et scientifiquement défendable des droits de la Nature.

← Retour au Radar

Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases

Identification

Clé publique
radar:r-87ca9ac3358cfe459f17b029021ff6eb
Auteurs
Arduino Aleksander Mangoni · Julie-Ann Hulin · Sara Tommasi
Année déclarée
2026
Langue déclarée
en
Type source
review
Première détection
2026-11-13T12:42:57.722431+00:00
Dernière observation des métadonnées
2026-11-13T12:42:57.722431+00:00
Dernière vérification HTTP
Non effectuée

Institutions déclarées par la source

Flinders University · Flinders Medical Centre

Pays d’affiliation déclarés

AU

Résumé documentaire — langue originale

Experimental and clinical evidence continues to accumulate, supporting the critical role of dysregulated inflammation, immunity, and redox signaling in the pathophysiology of various age-related cardiometabolic and neurodegenerative diseases. While ongoing research is investigating novel anti-inflammatory and immunomodulatory therapies for such conditions, available antirheumatic drugs may serve a similar purpose. One such drug, methotrexate, has been successfully used at high doses since the 1940s as an anticancer agent and, more recently, at lower doses in patients with autoimmune diseases. Although the effects of methotrexate have traditionally been attributed to its antiproliferative activity via folic acid modulation, additional targets have been identified, including AMP-activated protein kinase, Janus kinase/signal transducer and activator of transcription, high mobility group box 1 protein, the gut microbiota, and additional pharmacological effects of adenosine, a key mediator of methotrexate. The beneficial effects of modulating these targets on downstream inflammatory and immune pathways, cellular senescence, and vascular, metabolic, and brain homeostasis have been increasingly investigated in experimental models. Furthermore, studies conducted over the past 20 years suggest an association between low-dose methotrexate and a decreased risk of certain age-related cardiometabolic and neurodegenerative diseases, particularly in patients with autoimmune conditions. The results of these studies support the potential protective role of methotrexate against age-associated cardiometabolic and neurodegenerative diseases through multiple mechanisms, unlike targeted immunomodulatory and anti-inflammatory drugs, thereby providing a robust framework for investigating its repurposing in future intervention studies. SIGNIFICANCE STATEMENT: New treatments are essential to address the burden of age-related diseases. The important roles of dysregulated inflammation, immunity, and redox signaling in these conditions have spurred research into developing new therapies or repurposing existing drugs to target these dysfunctions. The disease-modifying antirheumatic drug methotrexate has shown potential protective effects against cellular senescence and certain age-related cardiometabolic and neurodegenerative diseases. This knowledge will encourage further research into the repurposing of methotrexate for the treatment of these diseases.

Identifiants

OPENALEX
https://openalex.org/W7164579400
DOI
10.1016/j.pharmr.2026.100147
PMID
https://pubmed.ncbi.nlm.nih.gov/42470822
PMCID
https://www.ncbi.nlm.nih.gov/pmc/articles/13689004

Repères documentaires

Famille documentaire
unknown
Types déclarés par les sources
review
Éditeurs
American Society for Pharmacology and Experimental Therapeutics

Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.

Sources

OpenAlex · Document 1

Citer cette référence

Arduino Aleksander Mangoni; Julie-Ann Hulin; Sara Tommasi. Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases. 2026. https://doi.org/10.1016/j.pharmr.2026.100147

JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·

APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.

APA
Arduino Aleksander Mangoni; Julie-Ann Hulin; Sara Tommasi. (2026). Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases. https://doi.org/10.1016/j.pharmr.2026.100147
Chicago
Arduino Aleksander Mangoni; Julie-Ann Hulin; Sara Tommasi. Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases. 2026. https://doi.org/10.1016/j.pharmr.2026.100147
ISO 690
Arduino Aleksander Mangoni; Julie-Ann Hulin; Sara Tommasi. Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases. 2026. https://doi.org/10.1016/j.pharmr.2026.100147

Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31

UDTR — Bibliothèque juridique mondiale des droits de la Nature. Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-87ca9ac3358cfe459f17b029021ff6eb/ · Dernière vérification HTTP : non effectuée

Signaler une correction

Données de cette version figée

Dossiers et relations documentaires

Rôles des sources

Source bibliographique / publication d’origine · https://doi.org/10.1016/j.pharmr.2026.100147

Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.

Statut documentaire

Pertinence à examiner

Bibliothèque

Cette identité n’est pas encore intégrée à la Bibliothèque juridique.

UDTR — Bibliothèque juridique mondiale des droits de la Nature